Structure-activity studies for α-amino-3-hydroxy-5-methyl-4- isoxazolepropanoic acid receptors: Acidic hydroxyphenylalanines

Journal of Medicinal Chemistry

Volumn 40, Issue 20, 1997, Pages 3182-3191

  Hill, Ronald A ^a,c,e   Wallace, Lane J ^a,d   Miller, Duane D ^a,b,c   Weinstein, David M ^a,d   Shams, Gamal ^a,d   Tai, Henry ^a,d   Layer, Richard T ^a,d   Willins, David ^a,d   Uretsky, Norman J ^a,d   Danthi, Satyavijayan Narasimhan ^a,e  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Departments of Medicinal Chemistry   (United States)

^d Div of Pharmacol/Exp Therapeut   (United States)

^e UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXY 3,5 DINITROPHENYLALANINE 2 HYDROXY 3,5 DINITROPHENYLALANINE; 3 HYDROXY 2,4 DINITROPHENYLALANINE; 6 HYDROXYDOPA; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR ANTAGONIST; PHENYLALANINE DERIVATIVE; UNCLASSIFIED DRUG; WILLARDIINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; NORADRENALIN RELEASE; RAT; RECEPTOR BLOCKING; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING, COMPETITIVE; BRAIN; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; ISOMERISM; MODELS, CHEMICAL; N-METHYLASPARTATE; PHENCYCLIDINE; QUINOXALINES; RADIOLIGAND ASSAY; RATS; RECEPTORS, AMPA; STRUCTURE-ACTIVITY RELATIONSHIP; TYROSINE;

EID: 9844263757     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950028z     Document Type: Article

References (58)

1. Monaghan, D. T.; Bridges, R. J.; Cotman, C. W. The Excitatory Amino Acid Receptors: Their Classes, Pharmacology, and Distinct Properties in the Function of the Central Nervous System. Anna. Rev. Pharmacol. Toxicol. 1989, 29, 365-402.
2. Headley, P. M.; Grillner, S. Excitatory amino acids and synaptic transmission: the evidence for a physiological function. Trends Pharmacol. Sci. 1990, 11, 205-211.
3. (a) Bettler, B.; Mulle, C. Review: Neurotransmitter Receptors II. AMPA and Kainate Receptors. Neuropharmacology 1995, 34, 123-139.
4. (b) Fletcher, E. J.; Lodge, D. New Developments in the Molecular Pharmacology of α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionate and Kainate Receptors. Pharmacol. Ther. 1996, 70, 65-89.
5. We first reported the initial test results for compounds 10, 11, and 13 in October 1989 (Hill, R. A.; Wallace, L. J.; Layer, R.; Miller, D. D.; Uretsky, N. J. Paper 519, American Association of Pharmaceutical Scientists Fourth Annual Meeting, Atlanta, GA, Oct. 24, 1989), and the antagonist activity of 13 along with preliminary results for several of the other compounds in March 1991 (Hill, R. A.; Miller, D. D.; Wallace, L. J.; Uretsky, N. J.; Layer, R.; Willins, D.; Supko, D.; Weinstein, D.; Tai, H. Abstract MEDI 0031, 201st American Chemical Society National Meeting, Atlanta, GA, Apr. 16, 1991).
6. We first reported the initial test results for compounds 10, 11, and 13 in October 1989 (Hill, R. A.; Wallace, L. J.; Layer, R.; Miller, D. D.; Uretsky, N. J. Paper 519, American Association of Pharmaceutical Scientists Fourth Annual Meeting, Atlanta, GA, Oct. 24, 1989), and the antagonist activity of 13 along with preliminary results for several of the other compounds in March 1991 (Hill, R. A.; Miller, D. D.; Wallace, L. J.; Uretsky, N. J.; Layer, R.; Willins, D.; Supko, D.; Weinstein, D.; Tai, H. Abstract MEDI 0031, 201st American Chemical Society National Meeting, Atlanta, GA, Apr. 16, 1991).
7. Subasinghe, N.; Schulte, M.; Roon, R. J.; Koerner, J. F.; Johnson, R. L. Quisqualic Acid Analogues: Synthesis of β-Heterocyclic 2-Aminopropanoic Acid Derivatives and Their Activity at a Novel Quisqualate-Sensitized Site. J. Med. Chem. 1992, 35, 4602-4607.
8. Matzen, L.; Engesgaard, A.; Ebert, B.; Didriksen, M.; Frølund, B.; Krogsgaard-Larsen, P.; Jaroszewski, J. W. AMPA Receptor Agonists: Synthesis, Protolytic Properties, and Pharmacology of 3-Isothiazolol Bioisosteres of Glutamic Acid. J. Med. Chem. 1997, 40, 520-527.
9. (a) Madsen, U.; Bang-Andersen, B.; Brehm, L.; Christensen, I. T.; Ebert, B.; Kristoffersen, I. T. S.; Lang, Y.; Krogsgaard-Larsen, P. Synthesis and Pharmacology of Highly Selective Carboxy and Phosphono Isoxazole Amino Acid AMPA Receptor Antagonists. J. Med. Chem. 1996, 39, 1682-1691.
10. (b) Krogsgaard-Larsen, P.; Ferkany, J. W.; Nielsen, E. Ø.; Madsen, U.; Ebert, B.; Johansen, J. S.; Diemer, N. H.; Bruhn, T.; Beattie, D. T.; Curtis, D. R. Novel Class of Amino Acid Antagonists at Non-N-methyl-D-aspartic Acid Excitatory Amino Acid Receptors, Synthesis, in Vitro and in Vivo Pharmacology, and Neuroprotection. J. Med. Chem. 1991, 34, 123-130.
11. 3H]-kainic acid. Brain Res. 1983, 265, 169-172.
12. (b) Agrawal, S. G.; Evans, R. H. The primary afferent depolarizing action of kainate in the rat. Br. J. Pharmacol. 1986, 87, 345-355.
13. (c) Evans, R. H.; Jones, A. W.; Watkins, J. C. Willardiine: a potent quisqualate-like excitant. J. Physiol. (London) 1980, 308, 71P-72P.
14. Patneau, D. K.; Mayer, M. L.; Jane, D. E.; Watkins, J. C. Activation and Desensitization of AMPA/Kainate Receptors by Novel Derivatives of Willardiine. J. Neurosci. 1992, 12, 595-606.
15. 3H]-AMPA to rat brain synaptic membranes: effects of a series of structural analogs of the non-NMDA receptor agonist willardiine. Neuropharmacology 1995, 34, 405-410.
16. Wong, L. A.; Mayer, M. L.; Jane, D. E.; Watkins, J. C. Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons. J. Neurosci. 1994, 14, 3881-3897.
17. (a) Biscoe, T. J.; Evans, R. H.; Headley, P. M.; Martin, M. R.; Watkins, J. C. Structure-Activity Relations of Excitatory Amino Acids on Frog and Rat Spinal Neurones. Br. J. Pharmacol. 1976, 58, 373-382.
18. (b) Bledsoe, S. C., Jr.; Chihal, D. M.; Bobbin, R. P.; Morgan, D. N. Comparative Actions of Glutamate and Related Substances on the Lateral Line of Xenopus Laevis. Comp. Biochem. Physiol. 1983, 75C, 199-206.
19. 3H]AMPA binding in rat striatum. Neurosci. Lett. 1991, 132, 55-58.
20. 3H]α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) binding in human hippocampus. Neurosci. Lett. 1994, 169, 219-222.
21. (c) Künig, G.; Niedermeyer, B.; Krause, F.; Hartmann, J.; Deckert, J.; Ransmayr, G.; Heinsen, H.; Beckmann, H.; Riederer, P. Interactions of neurotoxins with non-NMDA glutamate receptors: An autoradiographic study. J. Neural Transm., Suppl. 1994, 43, 59-62.
22. (a) Newcomer, T. A.; Rosenberg, P. A.; Aizenman, E. Iron-mediated oxidation of 3,4-dihydroxyphenylalanine to an excitotoxin. J. Neurochem. 1995, 64, 1742-1748.
23. (b) Newcomer, T. A.; Palmer, A. M.; Rosenberg, P. A.; Aizenman, E. Nonenzymic conversion of 3,4-dihydroxyphenylalanine to 2,4,5-trihydroxyphenylalanine and 2,4,5-trihydroxyphenylalanine quinone in physiological solutions. J. Neurochem. 1993, 61, 911-920.
24. (c) Aizenman, E.; Boeckman, F. A.; Rosenberg, P. A. Glutathione prevents 2,4,5-trihydroxyphenylalanine excitotoxicity by maintaining it in a reduced, non-active form. Neurosci. Lett. 1992, 144, 233-236.
25. Burckhalter, J. H.; Stephens, V. C. Synthesis of Phenylalanine Analogs as Antimetabolites. J. Am. Chem. Soc. 1951, 73, 56-58.
26. α-acylated fatty acids. Fiziol. Akt. Veshchestva 1988, 20, 11-16.
27. (b) Jankauskas, R.; Simkus, R.; Straukas, J. Synthesis and PMR spectroscopic study of the rotational isomerism of some derivatives of hydroxyand methoxy-m-nitrophenylalanines. Liet. TSR Mokslu Akad. Darb., Ser. B 1988, 78-83.
28. Dall'Asta, L.; Ferrario, P. Synthetische Versuche in der Gruppe der cytotoxisch wirksamen Substanzen: Darstellung von DL und L-3-[Di-(β-chloräthyl)-amino]-4-hydroxyphenylalanine. Helv. Chim. Acta 1962, 45, 1065-1071.
29. Jackson, E. L. Diiodo-m-tyrosine, Three Isomeric Dinitro-m-tyrosines and Some of their Derivatives. J. Am. Chem. Soc. 1955, 77, 4860-4864.
30. Jackson, E. L. The Synthesis of β-(3-Methoxy-2,6-dinitrophenyl)-D,L-alanine and β-(3-Methoxy-4,6-dinitrophenyl)-D,L-alanine. Proof of the Stuctures of Two Isomeric Dinitro-m-tyrosines. J. Am. Chem. Soc. 1957, 79, 2912-2915.
31. McCord, T. J.; Kreps, J. L.; Hubbard, J. N.; Davis, A. L. The Rearrangement of 3-Amino-3,4-dihydro-1-hydroxycarbostyril to 3-Amino-3,4-dihydro-6-hydroxycarbostyril. J. Heterocycl. Chem. 1969, 6, 937-939.
32. Ismail, I. A.; Sharp, D. E.; Chedekel, M. R. Synthesis of Benzothiazoles. α-Amino-(4-hydroxy-6-benzothiazolyl)propionic Acid. J. Org. Chem. 1980, 45, 2243-2246.
33. Albert, A.; Serjeant, E. P. The Determination of lonization Constants - A Laboratory Manual, 3rd ed.; Chapman and Hall: New York, 1984.
34. Lange's Handbook of Chemistry, 12th ed.; Dean, J. A., Ed.; McGraw-Hill: New York, 1979; pp 5.12-5.41.
35. Leupold, I.; Musso, H.; Einfluß von Substituenten auf die Acidität von 2,2′-Dihydroxybiphenylen. Liebigs Ann. Chem. 1971, 746, 134-148.
36. Based on measurements for similar compounds by Leupold and Musso, the value obtained by titration of 4-nitro-o-cresol in 50% methanol should be about 0.6 log unit higher than for spectroscopic determination in aqueous solution.
37. Pittaluga, A.; Raiteri, M. AMMethyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J. Pharmacol. Exp. Ther. 1992, 260, 232-237.
38. 3H]norepinephrine release from rat hippocampal slices. J. Neurochem. 1994, 63, 231-237.
39. Willins, D. L.; Wallace, L. J.; Miller, D. D.; Uretsky, N. J. α-Amino-3-hydroxy-5-methylisoxazole-4-propionate/Kainate Receptor Antagonists in the Nucleus Accumbens and Ventral Pallidum Decrease the Hypermotility Response to Psychostimulant Drugs. J. Pharmacol. Exp. Ther. 1992, 260, 1145-1151.
40. Results generated by the NovaScreen program (Nova Pharmaceutical Corp., Baltimore, MD) through a screening program of the National Institute of Mental Health.
41. Curtis, D. R.; Watkins, J. C. The excitation and depression of spinal neurons by structurally-related amino acids. J. Neurochem. 1960, 6, 117-141.
42. Kiss, T.; Toth, B. Microscopic processes of deprotonation of some tyrosine derivatives. Magy. Kem. Foly. 1981, 87, 374-380.
43. Madsen, U.; Schaumburg, K.; Brehm, L.; Curtis, D. R.; Krogsgaard-Larsen, P. Ibotenic Acid Analogues. Synthesis and Biological Testing of Two Bicyclic 3-Isoxazolol Amino Acids. Acta Chem. Scand., B 1986, 40, 92-97.
44. Boden, P.; Bycroft, B. W.; Chhabra, S. R.; Chiplin, J.; Crowley, P. J.; Grout, R. J.; King, T. J.; McDonald, E.; Rafferty, P.; Usherwood, P. N. R. The Action of Natural and Synthetic Isomers of Quisqualic Acid at a Well-Defined Glutamatergic Synapse. Brain Res. 1986, 385, 205-211.
45. Garcia-Sancho, J.; Sanchez, A.; Christensen, H. N. Role of Proton Dissociation in the Transport of Acidic Amino Acids by the Ehrlich Ascites Tumor Cell. Biochim. Biophys. Acta 1977, 464, 295-312.
46. Chan, P. C. M.; Roon, R. J.; Koerner, J. F.; Taylor, N. J.; Honek, J. F. A 3-Amino-4-hydroxy-3-cyclobutene-1,2-dione-Containing Glutamate Analogue Exhibiting High Affinity to Excitatory Amino Acid Receptors. J. Med. Chem. 1995, 38, 4433-4438.
47. Walker, R. J.; Roberts, C. J. Neuropharmacological Studies on the Receptors Mediating Responses to Carbachol, Amino Acids and Octopamine on Limulus and Hirudo Central Neurons. Comp. Biochem. Physiol., C 1984, 77C, 371-380.
48. 3H]α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid binding by the excitotoxin β-N-oxalyl-L-α,β-diaminopropionic acid. Eur. J. Pharmacol. 1988, 145, 357-359.
49. (b) Ross, S. M.; Roy, D. N.; Spencer, P. S. β-N-Oxalylamino-L-Alanine Action on Glutamate Receptors. J. Neurochem. 1989, 53, 710-715.
50. Nielsen, E. Ø.; Madsen, U.; Schaumburg, K.; Brehm, L.; Krogsgaard-Larsen, P. Studies on receptor-active conformations of excitatory amino acid agonists and antagonists. Eur. J. Med. Chem. - Chim. Ther. 1986, 21, 433-437.
51. Madsen, U.; Wong, E. H. F. Heterocyclic Amino Acids. Synthesis and Biological Activity of Novel Analogues of AMPA. J. Med. Chem. 1992, 35, 107-111.
52. Slavica, M.; Brooks, K.; Uretsky, N.; Wallace, L.; Miller, D. D. Abstract MEDI 181, 207th American Chemical Society National Meeting, San Diego, CA, March 1994.
53. Hansen, J. J.; Lauridsen, J.; Nielsen, E.; Krogsgaard-Larsen, P. Enzymic Resolution and Binding to Rat Brain Membranes of the Glutamic Acid Agonist α-Amino-3-hydroxy-5-methyl-4-isox-azolepropionic Acid. J. Med. Chem. 1983, 26, 901-903.
54. Martinez, A. P.; Lee, W. W. An Improved Synthesis of Willardiine and 1-(2′,2′-Diethoxyethyl)uracil. J. Org. Chem. 1965, 30, 317-318.
55. Martinez, A. P.; Lee, W. W.; Goodman, L. DL-Willardiine Mustard. J. Med. Chem. 1968, 21, 60-62.
56. Metzger, C. M.; Weiner, D. M. Program NONLIN84, Version V02-A; Statistical Consultants, Inc., 1984.
57. 3H]AMPA, a Structural Analog of Glutamic Acid, to Rat Brain Membranes. J. Neurochem. 1982, 38, 173.
58. Chou, T. C.; Talalay, P. Analysis of combined drug effects: a new look at a very old problem. Trends Pharmacol. Sci. 1983, 4, 450-454.